BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12112109)

  • 41. Complex relationship between Parkin mutations and Parkinson disease.
    West A; Periquet M; Lincoln S; Lücking CB; Nicholl D; Bonifati V; Rawal N; Gasser T; Lohmann E; Deleuze JF; Maraganore D; Levey A; Wood N; Dürr A; Hardy J; Brice A; Farrer M;
    Am J Med Genet; 2002 Jul; 114(5):584-91. PubMed ID: 12116199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pseudo-heterozygous rearrangement mutation of parkin.
    Funayama M; Yoshino H; Li Y; Kusaka H; Tomiyama H; Hattori N
    Mov Disord; 2012 Apr; 27(4):552-5. PubMed ID: 22308057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.
    Periquet M; Lücking C; Vaughan J; Bonifati V; Dürr A; De Michele G; Horstink M; Farrer M; Illarioshkin SN; Pollak P; Borg M; Brefel-Courbon C; Denefle P; Meco G; Gasser T; Breteler MM; Wood N; Agid Y; Brice A;
    Am J Hum Genet; 2001 Mar; 68(3):617-26. PubMed ID: 11179010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations.
    Broussolle E; Lücking CB; Ginovart N; Pollak P; Remy P; Dürr A
    Neurology; 2000 Sep; 55(6):877-9. PubMed ID: 10994015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism.
    Maruyama M; Ikeuchi T; Saito M; Ishikawa A; Yuasa T; Tanaka H; Hayashi S; Wakabayashi K; Takahashi H; Tsuji S
    Ann Neurol; 2000 Aug; 48(2):245-50. PubMed ID: 10939576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism.
    Li Y; Tomiyama H; Sato K; Hatano Y; Yoshino H; Atsumi M; Kitaguchi M; Sasaki S; Kawaguchi S; Miyajima H; Toda T; Mizuno Y; Hattori N
    Neurology; 2005 Jun; 64(11):1955-7. PubMed ID: 15955953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial pathology in muscle of a patient with a novel parkin mutation.
    Hanagasi HA; Serdaroglu P; Ozansoy M; Basak N; Tasli H; Emre M
    Int J Neurosci; 2009; 119(10):1572-83. PubMed ID: 19922375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
    Vinish M; Prabhakar S; Khullar M; Verma I; Anand A
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):166-70. PubMed ID: 19734163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.
    van Duijn CM; Dekker MC; Bonifati V; Galjaard RJ; Houwing-Duistermaat JJ; Snijders PJ; Testers L; Breedveld GJ; Horstink M; Sandkuijl LA; van Swieten JC; Oostra BA; Heutink P
    Am J Hum Genet; 2001 Sep; 69(3):629-34. PubMed ID: 11462174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.
    Tan LC; Tanner CM; Chen R; Chan P; Farrer M; Hardy J; Langston JW
    Mov Disord; 2003 Jul; 18(7):758-63. PubMed ID: 12815654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and genetic analysis of juvenile parkinsonism in Russia].
    Zagorovskaia TB; Illarioshkin SN; Slominskiĭ PA; Ivanova-Smolenskaia IA; Markova ED; Limborskaia SA; Levin OS; Miloserdova OV; Proskokova TN; Bagyeva BKh; Brice A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):66-72. PubMed ID: 15554146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
    Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
    Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
    Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
    Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How much phenotypic variation can be attributed to parkin genotype?
    Lohmann E; Periquet M; Bonifati V; Wood NW; De Michele G; Bonnet AM; Fraix V; Broussolle E; Horstink MW; Vidailhet M; Verpillat P; Gasser T; Nicholl D; Teive H; Raskin S; Rascol O; Destée A; Ruberg M; Gasparini F; Meco G; Agid Y; Durr A; Brice A; ;
    Ann Neurol; 2003 Aug; 54(2):176-85. PubMed ID: 12891670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's disease.
    Benbunan BR; Korczyn AD; Giladi N
    J Neural Transm (Vienna); 2004 Jan; 111(1):47-57. PubMed ID: 14714215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genotype and phenotype analyses of three families with autosomal recessive juvenile parkinsonism].
    Guo JF; Tang BS; Zhang YH; Liu HJ; Yan XX; Chen T; Shen L; Jiang H; Xia K; Cai F; Pan Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):70-3. PubMed ID: 16456791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical findings in a large family with a parkin ex3delta40 mutation.
    Munhoz RP; Sa DS; Rogaeva E; Salehi-Rad S; Sato C; Medeiros H; Farrer M; Lang AE
    Arch Neurol; 2004 May; 61(5):701-4. PubMed ID: 15148147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism.
    Zimmermann M; Wilke C; Schulte C; Hoffmann J; Klopfer J; Reimold M; Brockmann K; Synofzik M
    Parkinsonism Relat Disord; 2018 Oct; 55():145-147. PubMed ID: 29910155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.